18. Ye Z, Feng L, Huang S, Li S, He Y, Li Y*. Expression of H60 on mice heart graft and influence of cyclosporine. Transplant Proc 2006; 38(7): 2168-2171.
19. Tan JY, Zhao N, Wu TX, Yang KH, Zhang JD, Tian JH, Liu YL, Wang KJ, Chen F, Li SF, Li YP*. Steroid withdrawal increases risk of acute rejection but reduces infection: a meta-analysis of 1681 cases in renal transplantation. Transplant Proc. 2006;38(7):2054-6.
20. Cao L, Li Y*, Cheng F, Li S, Long D. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line. Transplant Proc 2006; 38(7): 2207-2209.
21. Cheng F, Feng L, Li S, Tan J, Cao L, He Y, Z Ye, Y Li*. Yishen injection decreases the expression of H60 and RAE-1 genes in ischemic mice liver. Transplant Proc 2006; 38(7): 2210-2213.
22. Xiong W, Gao CJ, Lu XF, Cheng JQ, Li YP*. Prolonged cold preservation promotes the recipient's cell
gydjdsj.org.cn participating in neointima formation but delays the later graft arteriosclerosis in rat model. Transplant Proc. 2005 Jan-Feb; 37(1):312-5.
23. Jianjun Lei, Jingqiu Cheng, Youping Li*, Shengfu Li, Li Zhang. CD80, but not CD86, express on cultured murine keratinocyte stem cells Transplant Proc 2005; 37:289-291
24. Cheng F, Li YP*, Cheng JQ, Feng L, Li SF.The protective mechanism of Yisheng Injection against hepatic ischemia reperfusion injury in mice.World J Gastroenterol. 2004; 10(8): 1198-203.
25. L. Feng, Y. Xiong, F. Cheng, L. Zhang, S. Li and Y. Li*. Effect of ligustrazine on ischemia-reperfusion injury in murine kidney Transplant Proc, 36( 7):1949-1951
26. Y Li, K Wang, J Cheng, F Li, Y Ma, Y Yang. Human-pig spleen transplantation leading to high level of chemerism. Transplant Proc 2000, 32: 1103-4
27. Y. Li, T Li, H Bu, J Cheng, Y Chen，Z Yang. Xenoantigenacity of Chinese neijiang pig-related to xenotransplantation. Transplant Proc. 2000, 32: 875-6
28. Li YP*, T Li, H Bu, JQ Cheng, YY Chen, Z Yang. Xenoantigenacity of Chinese Neijiang pig-related to xenotransplantation. Transplant Proc. 2000, 32(5): 875-6.
29. Luo L, Lu J, Wei L, Long D, Guo JY, Shan J, Li FS, Lu PY, Li PY, Feng L. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/ reoxygenation. BMC Cell Biol. 2010;11(1):91
30. Zhang L, Li Y, Jiang H, Liu J, Zeng Y, Cheng J. Comparison of hepatic coagulant, fibrinolytic, and anticoagulant functions between Banna Minipig Inbred line and humans. Transplantation. 2005;79(9):1128-31.
31. S. Li, G. Feng, Y. Li, H. Bu, Y. Lu, Y. Yang. Direct peptide nucleic acid uptake in human dendritic cells. Transplantation Proceedings 2003, 35: 550-2
32. Lin Yan, Fen Lan, Zhen-Gang Wang, Youping Li*. Statins and myotoxicity. TRENDS in Pharmacological Science. 2003;24(3):113-114（影響因子=10.74)
33. Sun X, Chen X, Lin L, Zhou L, Ma T, Li X, Wang X, Peng K, Li Y*.Taxanes for advanced (metastatic and locally advanced) non-small cell lung cancer.The Cochrane Library, Issue 3, 2003
34. Xin Sun, Tao Ma, Xia Li, Qi Wang, Xia Zhang, Xinzu Chen, Youping Li*.Vinca alkaloid containing regimens for advanced breast cancer.The Cochrane Library, Issue 3, 2003
35. H. Zhang, Y. Li*, S. Li, K. Wang, J. Cheng. The status of chimeric cells in human-to-pig spleen transplantation. Transplantation Proceedings 2003, 35: 533-4
36. Hu weimin, Cheng jingqiu, Li youping*, Li shengfu, Lu xiaofeng and Wan lin. Identification of the candidate genes associated with cellular rejection in pig-to-human xenotransplantation, Progress in natural science, 2002; 12(9):77-79。
37. 王坤杰，張海濤，李幼平，盧一平，魏強(qiáng)，李虹，楊宇如. 中國循證醫(yī)學(xué)雜志2005,5(5):365-374
38. 鄢琳,曹立亞,雷建軍,蘭奮,李靜,肖愛麗,鄒燕,白雪,章渝,王超,張力文,李幼平*, 9種調(diào)血脂藥物有效性及安全性評價. 中國循證醫(yī)學(xué)雜志.2005,5(1):8-21
39. 鄒燕，李幼平*，雷貞武.
米非司酮配伍
米索前列醇藥物
流產(chǎn)的安全性評價.
中華婦產(chǎn)科雜志,2004,2004,4(1):39-42
40. 李幼平. 參與國際振興醫(yī)學(xué)科學(xué)行動，迎接21世紀(jì)醫(yī)學(xué)科學(xué)挑戰(zhàn).中國循證醫(yī)學(xué)雜志2004,4(18):437-438
41. 孫丁 李幼平* 馮曦兮 黃揩森 鐘鈴 甘靖 周榮 鄭靜 易嵐 曾錚 稅紅 劉挺 易剛. 從SARS防治績效對比研究各國公共衛(wèi)生應(yīng)急反應(yīng)體系.中國循證醫(yī)學(xué)雜志2004,4(17):402-409
42. 陶鐵軍 李幼平* 何林 孫丁 石應(yīng)康 劉進(jìn) 傅璟 胡娜 閔理 楊鏡 謝啟麟 洪雪丹 王瑩.循證制定我國�？漆t(yī)師培養(yǎng)方案和考核標(biāo)準(zhǔn)初探。中國循證醫(yī)學(xué)雜志2004,4(16):318-324
43. 張海濤，王坤杰，李幼平*，高勵，劉瑾，蔡羽嘉. 腎移植術(shù)后驍悉與
硫唑嘌呤抗排斥反應(yīng)隨機(jī)對照試驗的系統(tǒng)評價. 中國循證醫(yī)學(xué)雜志. 2004;4(13):79-91
44. 陶鐵軍，李幼平*，鄺璞
gydjdsj.org.cn，王莉，熊鷹，蔡羽嘉. 臨終醫(yī)療的衛(wèi)生技術(shù)評估系列研究I. 圍腦死亡期醫(yī)療服務(wù)的現(xiàn)狀及費用分析.中國循證醫(yī)學(xué)雜志2004,4(12): 29-35
45. 董碧蓉，曹立亞，周焱，徐英，蘭奮，舒德芬，肖愛麗，常薪霞，杜堅宗，王惠，李幼平*. 8種血管緊張素轉(zhuǎn)換酶抑制劑治療
高血壓的臨床療效、安全性及成本效果評估.中國循證醫(yī)學(xué)雜志2004,4(12):15-28
46.孫鑫，曹立亞，陳心足，蘭奮，李夏，肖愛麗，馬濤，李幼平*.四種抗變態(tài)反應(yīng)藥物的衛(wèi)生技術(shù)評估的研究方案.中國循證醫(yī)學(xué)雜志. 2003; 3(1): 35-40
47.鄒燕，李幼平*，呂琳等.藥物流產(chǎn)對再次妊娠影響的系統(tǒng)評價.中國循證醫(yī)學(xué)雜志2003, 3(3):187-193.
聯(lián)系方式:
電話： 028-85422075 郵箱:lishengfu@tom.com
上一頁 [1] [2] [3] [4] 下一頁
